Navigation Links
MBS Value Partners Hires Two New Senior Staff Members

NEW YORK, Feb. 8 /PRNewswire/ -- MBS Value Partners, a strategic communications firm specializing in investor relations and corporate communications for domestic and international clients, announced today that Lisa Lettieri and Matthew Haines have joined as Managing Directors.

“Lisa and Matt bring outstanding senior-level advisory and corporate experience that will serve our clients well,” said Lynn Morgen, co-founder of MBS. “Lisa’s and Matt’s significant experience in clean technology and health care / biotechnology, respectively, complement our existing expertise in technology, business/industrial services, media and consumer businesses, and will enable us to further leverage our knowledge base, network of financial community relationships and crisis expertise for the benefit of our clients."

Lisa Lettieri brings more than a dozen years of integrated corporate communications and strategic planning experience to MBS. Most recently she headed Investor Relations and Corporate Communications for FuelCell Energy, a Nasdaq-listed manufacturer of high-efficiency ultra-clean power plants headquartered in Danbury, Connecticut. Prior to that she was Vice President of Investor Relations at Champion Enterprises, Inc., a factory homebuilder and was previously Director of Corporate Communications with responsibility for investor relations at Scientific Games Corporation. Lisa was an institutional investment professional for 15 years prior to becoming a corporate communications specialist. She holds a BS in Marketing from Manhattan College and an MBA in Finance from Fordham University in New York.

Matt Haines brings more than 20 years of investor relations, media relations, and corporate communications experience in health care and biotechnology. Prior to joining MBS, Matt served as Senior Director of Investor Relations and Corporate Communications at MDRNA, Inc., a biotechnology company developing RNAi therapeutics and delivery systems. Earlier, Matt served as Senior Director of Investor Relations and Corporate Communications at Nastech Pharmaceutical Company Inc. and as Director of Corporate Communications at OSI Pharmaceuticals, Inc. Matt's career includes almost 10 years of health care agency experience in increasingly responsible positions. Matt holds a BA in Political Science from New York University and an MBA in Marketing from NYU's Stern School of Business.


MBS Value Partners, headquartered in New York City, is a strategic communications firm that provides senior level advisory work and customized investor relations, financial media and corporate communications programs for a growing roster of domestic and international clients. For additional information, please visit

SOURCE MBS Value Partners



SOURCE MBS Value Partners
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
2. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
3. Industry Executives Finding Value in Shift of Scientific Publications
4. Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. ValueRich Report on AMDL/China Available on Web Site
7. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
8. AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually
9. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
10. Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
11. Industry Executives Finding Value in Shift of Scientific Publications
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 Studies ... and human plaque and pave the way for more effective ... in cats     --> ... commonly diagnosed health problems in cats, yet relatively little was ... Two collaborative studies have been conducted by researchers from the ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a ... leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, ...
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
Breaking Biology Technology:
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
Breaking Biology News(10 mins):